These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3105751)

  • 1. Chlorpromazine induced fluid retention masquerading as idiopathic oedema.
    Witz L; Shapiro MS; Shenkman L
    Br Med J (Clin Res Ed); 1987 Mar; 294(6575):807-8. PubMed ID: 3105751
    [No Abstract]   [Full Text] [Related]  

  • 2. Double blind study of clopenthixol and chlorpromazine in acute hospitalized schizophrenics.
    Kingstone E; Kolivakis T; Kossatz I
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):41-5. PubMed ID: 4909377
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlorpromazine-induced lenticular opacity.
    Srinivasan K; Gopalakrishna M
    Indian J Pharmacol; 2020; 52(4):339-340. PubMed ID: 33078739
    [No Abstract]   [Full Text] [Related]  

  • 4. [A double-blind controlled study of the efficacy and side effects of thioridazine and chlorpromazine in schizophrenia].
    Guo GY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):300-2, 319-20. PubMed ID: 3234163
    [No Abstract]   [Full Text] [Related]  

  • 5. Chlorpromazine-induced severe skin pigmentation and corneal opacities in a patient with schizophrenia.
    Molina-Ruiz AM; Pulpillo Á; Molina-Ruiz RM; Sagrario T; Requena L
    Int J Dermatol; 2016 Aug; 55(8):909-12. PubMed ID: 26340849
    [No Abstract]   [Full Text] [Related]  

  • 6. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
    Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
    J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
    [No Abstract]   [Full Text] [Related]  

  • 7. Negligible hepatotoxicity of chlorpromazine in long-term therapy.
    Weinreb M; Kraus V; Krausová J; Hudcová T
    Act Nerv Super (Praha); 1978 Dec; 20(4):280-1. PubMed ID: 735735
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlorpromazine-induced corneal toxicity.
    Koh V; Khor WB; Lim L
    Arch Ophthalmol; 2012 Nov; 130(11):1409. PubMed ID: 23143440
    [No Abstract]   [Full Text] [Related]  

  • 9. Clomacran and chlorpromazine in psychotic outpatients: a controlled study.
    Case WG; Ryder BL; Dhopeshwarkar VP; Pereira-Ogan JA; Rickels K
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):337-43. PubMed ID: 4996219
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of two antipsychotic drugs: chlorpromazine and clozapine (author's transl)].
    Dick P; Rémy M; Rey-Bellet JJ
    Ther Umsch; 1975 Aug; 32(8):497-500. PubMed ID: 1099714
    [No Abstract]   [Full Text] [Related]  

  • 11. Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
    Gelenberg AJ; Doller JC
    J Clin Psychiatry; 1979 May; 40(5):238-40. PubMed ID: 374401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios.
    Sakalis G; Chan TL; Sathananthan G; Schooler N; Goldberg S; Gershon S
    Commun Psychopharmacol; 1977; 1(2):157-66. PubMed ID: 342185
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled comparison of SK&F 14336 and chlorpromazine in newly admitted schizophrenics.
    Overall JE; Hollister LE; Prusmack JJ; Shelton J; Pokorny A
    J Clin Pharmacol J New Drugs; 1969; 9(5):328-38. PubMed ID: 4899114
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics.
    Freeman H
    Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pure intracellular cholestasis. Ultrastructural studies of 2 cases of Dubin-Johnson syndrome and non-icteric patients treated with chlorpromazine].
    Barone P
    Virchows Arch Pathol Anat Physiol Klin Med; 1966 Apr; 341(1):43-53. PubMed ID: 5299819
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term changes in AIMS ratings and their relation to medication history [proceedings].
    Smith JM; Burke MP; Moon CO
    Psychopharmacol Bull; 1981 Jan; 17(1):120-1. PubMed ID: 7232640
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: A comparative study of thiothixene and chlorpromazine in chronic schizophrenic patients: application of a special psychometric test battery.
    Ruiz-Navarro JF; Vergara L; Deutsch M
    Psychopharmacol Bull; 1976 Jan; 12(1):38-9. PubMed ID: 1108083
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of caloric restriction on behavior and body weight during chlorpromazine therapy.
    Sletten I; Cazenave M; Gershon S
    Dis Nerv Syst; 1967 Aug; 28(8):519-22. PubMed ID: 6048414
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative double blind study between chlozapine and chlorpromazine in schizophrenia].
    Ruíz Ruíz M
    Arch Neurobiol (Madr); 1974 Mar; 37(2):169-80. PubMed ID: 4600866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.